Discontinued — last reported Q2 '24
Non-Current Assets
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)
Gilead Sciences Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) increased by 4.4% to $1.98B in Q3 2025 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ1 2021
Last reportedQ2 2024
Metric ID:
afs_debt_securities_fair_value_maturing_1_to_5yHistorical Data
10 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $814.00M | $1.08B | $1.41B | $1.34B | $1.30B | $1.33B | $1.33B | $1.16B | $1.90B | $1.98B |
| QoQ Change | — | +32.1% | +31.5% | -5.4% | -3.0% | +2.1% | +0.5% | -12.8% | +63.7% | +4.4% |
| YoY Change | — | — | — | +64.4% | +20.7% | -6.3% | -0.4% | -10.6% | — | — |
Range$814.00M – $1.98B
CAGR+48.6%
Avg YoY Growth+13.6%
Median YoY Growth-0.4%
Current Streak2 quarters growth
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's available-for-sale debt securities - fair value (maturing 1 to 5 years)?
- Gilead Sciences (GILD) reported available-for-sale debt securities - fair value (maturing 1 to 5 years) of $1.98B in Q3 2025.